Evidence map›Paper›PMID 34956876›Full record

ArticleFrontiers in oncology2021

Circadian Influences on Chemotherapy Efficacy in a Mouse Model of Brain Metastases of Breast Cancer.

William H Walker, Samuel A Sprowls, Jacob R Bumgarner, Jennifer A Liu, O Hecmarie Meléndez-Fernández, James C Walton, Paul R Lockman, A Courtney DeVries, Randy J Nelson

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

William H WalkerDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States.
Samuel A SprowlsDepartment of Pharmaceutical Sciences, West Virginia University, Morgantown, WV, United States.
Jacob R BumgarnerDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States.
Jennifer A LiuDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States.
O Hecmarie Meléndez-FernándezDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States.
James C WaltonDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States.
Paul R LockmanDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States.
A Courtney DeVriesDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States.
Randy J NelsonDepartment of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States.
Blanchette Rockefeller Neurosciences Institute · USWest Virginia University · USWest Virginia State University · US

Funding

WVU Flow Cytometry and Single Cell Core Facility (FCSCCF)P20GM121322 · NIGMS · WEST VIRGINIA UNIVERSITY · PI KATHLEEN M BRUNDAGE · 2018 to 2026
$22.4M
Stroke and Alzheimers Disease Related DementiasT32AG052375 · NIA · WEST VIRGINIA UNIVERSITY · PI Paul D Chantler, BERNARD G. SCHREURS · 2017 to 2026
$3.5M
Sex Differences in Blood-Brain and Blood-Tumor Barrier Dynamics in GlioblastomaK00CA253768 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SPROWLS, SAMUEL ADAM TYLER · 2022 to 2024
$281k
NCI NIH HHS K00 CA253768NIA NIH HHS T32 AG052375NIGMS NIH HHS P20 GM121322
6 · The paper itself

Abstract

Chemotherapy is more effective in the treatment of peripheral tumors than brain metastases, likely reflecting the reduced ability of chemotherapy to cross the blood-brain barrier (BBB) and blood-tumor barrier at efficacious concentrations. Recent studies demonstrate circadian regulation of the BBB. Thus, we predicted that optimally timed chemotherapy would increase anti-tumor efficacy in a model of brain metastases of breast cancer (BMBC). First, we characterized novel daily alterations in BBB permeability to a commonly used chemotherapeutic,

Indexed as

blood-brain barrierbrain metastasesbreast cancerchronotherapeuticcircadian rhythm

Identifiers

PMID34956876
PMCPMC8695439
OpenAlexW4200534984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.